Mapping EQ-5D utility scores from the PedsQL™ generic core scales.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Works matching IS 11707690 AND DT 2014 AND VI 32 AND IP 7
Results: 9
1
2
A Review of the Economics of Treating Clostridium difficile Infection.
- Published in:
- PharmacoEconomics, 2014, v. 32, n. 7, p. 639, doi. 10.1007/s40273-014-0161-y
- By:
- Publication type:
- Article
3
Barriers to the Uptake of Biosimilars and Possible Solutions: A Belgian Case Study.
- Published in:
- PharmacoEconomics, 2014, v. 32, n. 7, p. 681, doi. 10.1007/s40273-014-0163-9
- By:
- Publication type:
- Article
4
Mapping EQ-5D Utility Scores from the PedsQL™ Generic Core Scales.
- Published in:
- PharmacoEconomics, 2014, v. 32, n. 7, p. 693, doi. 10.1007/s40273-014-0153-y
- By:
- Publication type:
- Article
5
Cost-Effectiveness Analysis of Interventions for Tuberculosis Control: DALYs Versus QALYs.
- Published in:
- PharmacoEconomics, 2014, v. 32, n. 7, p. 617, doi. 10.1007/s40273-014-0159-5
- By:
- Publication type:
- Article
6
Challenges in Modelling the Cost Effectiveness of Various Interventions for Cardiovascular Disease.
- Published in:
- PharmacoEconomics, 2014, v. 32, n. 7, p. 627, doi. 10.1007/s40273-014-0155-9
- By:
- Publication type:
- Article
7
NICE's Cost-Effectiveness Range: Should it be Lowered?
- Published in:
- PharmacoEconomics, 2014, v. 32, n. 7, p. 613, doi. 10.1007/s40273-014-0158-6
- By:
- Publication type:
- Article
8
Cost-Effectiveness Analyses of Targeted Oral Anti-Cancer Drugs: A Systematic Review.
- Published in:
- PharmacoEconomics, 2014, v. 32, n. 7, p. 651, doi. 10.1007/s40273-014-0160-z
- By:
- Publication type:
- Article
9
Cost-Effectiveness Analysis of Docetaxel Versus Weekly Paclitaxel in Adjuvant Treatment of Regional Breast Cancer in New Zealand.
- Published in:
- PharmacoEconomics, 2014, v. 32, n. 7, p. 707, doi. 10.1007/s40273-014-0154-x
- By:
- Publication type:
- Article